
Martlet Capital
Europe, Cambridgeshire, United Kingdom, Cambridge'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Description
Martlet Capital is an early-stage investor, providing patient capital to deep tech and life science start-ups with high growth potential.
Investor Profile
Martlet Capital has made 49 investments, with 2 in the past 12 months and 12% as lead.
Stage Focus
- Seed (57%)
- Series A (20%)
- Pre Seed (8%)
- Angel (6%)
- Series B (6%)
- Series Unknown (2%)
Country Focus
- United Kingdom (96%)
- United States (4%)
Industry Focus
- Biotechnology
- Health Care
- Software
- Information Technology
- Pharmaceutical
- Artificial Intelligence (Ai)
- Medical
- Network Security
- Quantum Computing
- Telecommunications
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.